Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07534423
Recruiting Observational

Post-Debonding Finishing in Orthodontics

NCT07534423 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Roma La Sapienza
Phase
Observational
Started
2024-01-01
Last updated
2026-04-20

Condition(s) studied

CariesEnamel Lesions

Study summary

This study investigates clinical approaches to orthodontic debonding and post-debonding finishing, focusing on enamel preservation. An observational epidemiological survey was conducted among dental professionals to assess commonly used techniques, instruments, and complications. Results highlight variability in clinical protocols, with mechanical methods being the most widely adopted. The study emphasizes the importance of minimally invasive strategies to reduce enamel damage and improve patient outcomes.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Professional Background: Must be a dental professional with specific clinical knowledge and practical skills required to perform orthodontic therapies. * Specialization: Eligible participants must fall into one of the following categories: Orthodontist (Specialist), General Dentist with demonstrated clinical competence in orthodontics, Resident/Post-graduate student specializing in Orthodontics and Dentofacial Orthopedics. Exclusion Criteria: * Non-Orthodontic Professionals: Dental professionals who do not belong to the categories mentioned above are excluded, even if they work within the dental field. * Lack of Specific Competence: Practitioners who do not possess the necessary clinical expertise to perform orthodontic debonding and finishing procedures. * Incomplete Participation: Failure to provide informed consent or complete the mandatory sections of the epidemiological survey.

Primary outcome measure(s)

  • Prevalence and Type of Iatrogenic Enamel Damage Post-Orthodontic Debonding — At the completion of the orthodontic treatment (immediate post-debonding phase).
    Evaluation of the frequency and nature of enamel alterations (e.g., fractures, scratches, or surface roughness) observed by practitioners following the removal of orthodontic brackets and residual resin. This measure assesses the clinical impact of different debonding and finishing protocols on enamel integrity. Higher scores indicate a worse outcome (higher frequency of iatrogenic damage)
  • Frequency of Patient-Reported Dental Sensitivity and Pain — From the start of the debonding procedure up to the first follow-up visit (typically within a few weeks).
    Assessment of the incidence of hypersensitivity (to thermal or tactile stimuli) and discomfort/pain reported by patients during or immediately after the debonding and finishing procedures.

Trial sites (1)

FacilityCityRegionStatus
Sapienza università di Roma Roma RM Recruiting

More University of Roma La Sapienza trials in Italy

Palatal Mucosa Wound Healing Following Antimicrobial Gel Application Active, not recruiting
The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth: Recruiting
Itaca App vs. Usual Care for Medication Adherence in Older Adults on Polypharmacy Active, not recruiting
Gummy Smile and Altered Passive Eruption Prevalence Recruiting
Use of 'Mechanical Power' as a Predictor of Increased Serum and Pulmonary Proinflammatory Cytokine Concentrations in Patients With Acute Hypoxemic Respiratory Failure: A Prospective Observational Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07534423 on ClinicalTrials.gov ↗ ← All trials in Italy